Palo Alto, United States
Centrillion Technology, Inc., founded in 2009, is a U.S.-based leader in the fusion of Biotechnology and Life Sciences, targeting the burgeoning fields of personalized health care and molecular diagnostics. Their innovative DNA chips aim to map biological molecules at the sub-cellular level, positioning them uniquely within the market.
The core mission of Centrillion Tech is to democratize genomic information, enabling more responsible and cost-effective access for researchers, physicians, and consumers. This strategic approach is bolstered by their focus on bridging technologies that tackle the challenges in large-scale genomic analyses and informatics.
Despite not having publicly noted investment partners from their Corporate Round on 01 August 2018, their high-quality genomic services have earned positive reception from both academic and industrial clients. Investors seeking a foothold in biotech and personalized medicine should consider Centrillion as a valuable prospect.
KSITEST
GenoSensor Corporation